$MOGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MGI PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MGI PHARMA INC. Get notifications about new insider transactions in MGI PHARMA INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 01 2006 | MOGN | MGI PHARMA INC | Loukas Eric P | Exec VP, COO, Gen C ... | Option Exercise | A | 15.13 | 75,000 | 1,134,750 | 75,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Loukas Eric P | Exec VP, COO, Gen C ... | Grant | A | 0.00 | 20,000 | 0 | 25,212 | 5.2 K to 25.2 K (+383.73 %) |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Spengler William | Executive VP, CFO | Option Exercise | A | 15.13 | 75,000 | 1,134,750 | 75,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Spengler William | Executive VP, CFO | Grant | A | 0.00 | 10,000 | 0 | 49,856 | 39.9 K to 49.9 K (+25.09 %) |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | A | 15.13 | 75,000 | 1,134,750 | 75,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Grant | A | 0.00 | 20,000 | 0 | 26,223 | 6.2 K to 26.2 K (+321.39 %) |
| Sep 01 2006 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Option Exercise | A | 15.13 | 80,000 | 1,210,400 | 80,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Grant | A | 0.00 | 20,000 | 0 | 221,889 | 201.9 K to 221.9 K (+9.91 %) |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Rodgers Richard J | VP & Controller | Option Exercise | A | 15.13 | 20,000 | 302,600 | 20,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Rodgers Richard J | VP & Controller | Grant | A | 0.00 | 4,000 | 0 | 7,277 | 3.3 K to 7.3 K (+122.06 %) |
| Aug 16 2006 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Buy | P | 14.02 | 2,000 | 28,040 | 5,675 | 3.7 K to 5.7 K (+54.42 %) |
| Aug 10 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Buy | P | 13.69 | 4,000 | 54,760 | 39,445 | 35.4 K to 39.4 K (+11.29 %) |
| Aug 08 2006 | MOGN | MGI PHARMA INC | Spengler William | Executive VP, CFO | Buy | P | 13.85 | 1,000 | 13,850 | 39,856 | 38.9 K to 39.9 K (+2.57 %) |
| Aug 08 2006 | MOGN | MGI PHARMA INC | TUTTLE WANETA C | Director | Buy | P | 13.64 | 1,500 | 20,460 | 2,000 | 500 to 2 K (+300.00 %) |
| Aug 08 2006 | MOGN | MGI PHARMA INC | TUTTLE WANETA C | Director | Buy | P | 13.63 | 500 | 6,815 | 500 | 0 to 500 |
| Aug 08 2006 | MOGN | MGI PHARMA INC | WEAVER ARTHUR L | Director | Buy | P | 13.94 | 2,000 | 27,880 | 2,000 | 0 to 2 K |
| Aug 08 2006 | MOGN | MGI PHARMA INC | SHARROCK DAVID B | Director | Buy | P | 14.00 | 2,000 | 28,000 | 6,000 | 4 K to 6 K (+50.00 %) |
| Aug 08 2006 | MOGN | MGI PHARMA INC | SHARROCK DAVID B | Director | Buy | P | 13.61 | 2,000 | 27,210 | 4,000 | 2 K to 4 K (+100.00 %) |
| Aug 07 2006 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | P | 14.15 | 700 | 9,905 | 202,589 | 201.9 K to 202.6 K (+0.35 %) |
| Aug 07 2006 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | P | 14.16 | 1,300 | 18,408 | 201,889 | 200.6 K to 201.9 K (+0.65 %) |
| Jul 25 2006 | MOGN | MGI PHARMA INC | Armitage James O | Director | Option Exercise | A | 14.68 | 15,000 | 220,200 | 15,000 | |
| Jul 17 2006 | MOGN | MGI PHARMA INC | Rodgers Richard J | VP & Controller | Payment of Exercise | F | 20.58 | 78 | 1,605 | 3,277 | 3.4 K to 3.3 K (-2.32 %) |
| Jul 17 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Sr. VP & Chief Scie ... | Payment of Exercise | F | 20.58 | 277 | 5,701 | 3,223 | 3.5 K to 3.2 K (-7.91 %) |
| Jul 17 2006 | MOGN | MGI PHARMA INC | Loukas Eric P | VP, General Cousel ... | Payment of Exercise | F | 20.58 | 288 | 5,927 | 5,212 | 5.5 K to 5.2 K (-5.24 %) |
| Jul 17 2006 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Payment of Exercise | F | 20.58 | 411 | 8,458 | 200,589 | 201 K to 200.6 K (-0.20 %) |
| Jul 05 2006 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Option Exercise | A | 21.63 | 15,000 | 324,450 | 15,000 | |
| Jul 05 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 21.50 | 291 | 6,257 | 35,445 | 35.2 K to 35.4 K (+0.83 %) |
| Jul 05 2006 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 21.50 | 291 | 6,257 | 3,675 | 3.4 K to 3.7 K (+8.60 %) |
| May 10 2006 | MOGN | MGI PHARMA INC | Spengler William | Sr. VP, CFO | Grant | A | 0.00 | 18,000 | 0 | 38,856 | 20.9 K to 38.9 K (+86.31 %) |
| May 10 2006 | MOGN | MGI PHARMA INC | WEAVER ARTHUR L | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| May 10 2006 | MOGN | MGI PHARMA INC | TUTTLE WANETA C | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| May 10 2006 | MOGN | MGI PHARMA INC | SHARROCK DAVID B | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| May 10 2006 | MOGN | MGI PHARMA INC | MEHRER EDWARD W | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| May 10 2006 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| Apr 25 2006 | MOGN | MGI PHARMA INC | Spengler William | Sr. VP, CFO | Option Exercise | A | 17.84 | 25,000 | 446,000 | 25,000 | |
| May 10 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Option Exercise | A | 19.67 | 15,000 | 295,050 | 15,000 | |
| Apr 24 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Option Exercise | M | 2.44 | 15,000 | 36,563 | 0 | |
| Apr 24 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Buy | M | 2.44 | 15,000 | 36,563 | 35,154 | 20.2 K to 35.2 K (+74.43 %) |
| Apr 03 2006 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 17.50 | 286 | 5,005 | 3,337 | 3.1 K to 3.3 K (+9.37 %) |
| Apr 03 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 17.50 | 286 | 5,005 | 20,107 | 19.8 K to 20.1 K (+1.44 %) |
| Jan 03 2006 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 17.16 | 292 | 5,011 | 19,821 | 19.5 K to 19.8 K (+1.50 %) |
| Jan 03 2006 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 17.16 | 292 | 5,011 | 3,051 | 2.8 K to 3.1 K (+10.58 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | Loukas Eric P | VP, General Counsel ... | Grant | A | 0.00 | 2,000 | 0 | 5,500 | 3.5 K to 5.5 K (+57.14 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Gift | G | 0.00 | 150 | 0 | 6,500 | 6.7 K to 6.5 K (-2.26 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Gift | G | 0.00 | 150 | 0 | 6,650 | 6.8 K to 6.7 K (-2.21 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Buy | P | 16.50 | 150 | 2,475 | 6,800 | 6.7 K to 6.8 K (+2.26 %) |
| Dec 20 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Buy | P | 16.51 | 150 | 2,476 | 6,650 | 6.5 K to 6.7 K (+2.31 %) |
| Oct 28 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | P | 18.86 | 200 | 3,772 | 201,000 | 200.8 K to 201 K (+0.10 %) |
| Oct 28 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | P | 18.85 | 500 | 9,425 | 200,800 | 200.3 K to 200.8 K (+0.25 %) |
| Oct 28 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | P | 18.84 | 1,300 | 24,492 | 200,300 | 199 K to 200.3 K (+0.65 %) |
| Oct 27 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Buy | P | 18.95 | 500 | 9,475 | 19,529 | 19 K to 19.5 K (+2.63 %) |
| Oct 27 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Buy | P | 19.00 | 500 | 9,500 | 19,029 | 18.5 K to 19 K (+2.70 %) |
| Oct 06 2005 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Sr. VP & Chief Scie ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Option Exercise | A | 23.56 | 15,000 | 353,400 | 15,000 | |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.48 | 4,000 | 93,920 | 6,148 | 10.1 K to 6.1 K (-39.42 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.40 | 5,023 | 117,538 | 10,148 | 15.2 K to 10.1 K (-33.11 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.33 | 3,926 | 91,594 | 15,171 | 19.1 K to 15.2 K (-20.56 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.31 | 5,095 | 118,764 | 19,097 | 24.2 K to 19.1 K (-21.06 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.21 | 5,000 | 116,050 | 24,192 | 29.2 K to 24.2 K (-17.13 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.41 | 13,750 | 321,888 | 29,192 | 42.9 K to 29.2 K (-32.02 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.35 | 5,000 | 116,752 | 42,942 | 47.9 K to 42.9 K (-10.43 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.31 | 1,005 | 23,429 | 47,942 | 48.9 K to 47.9 K (-2.05 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.47 | 2,000 | 46,940 | 48,947 | 50.9 K to 48.9 K (-3.93 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.45 | 5,000 | 117,250 | 50,947 | 55.9 K to 50.9 K (-8.94 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.42 | 3,077 | 72,055 | 55,947 | 59 K to 55.9 K (-5.21 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.25 | 2,000 | 46,500 | 59,024 | 61 K to 59 K (-3.28 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.51 | 100 | 2,351 | 61,024 | 61.1 K to 61 K (-0.16 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.33 | 4,000 | 93,300 | 61,124 | 65.1 K to 61.1 K (-6.14 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.46 | 1,424 | 33,407 | 65,124 | 66.5 K to 65.1 K (-2.14 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | MITCHELL DEAN J | Director | Sell | S | 23.40 | 100 | 2,340 | 66,548 | 66.6 K to 66.5 K (-0.15 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Grant | A | 0.00 | 3,000 | 0 | 6,500 | 3.5 K to 6.5 K (+85.71 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO | Grant | A | 0.00 | 2,000 | 0 | 6,000 | 4 K to 6 K (+50.00 %) |
| Oct 05 2005 | MOGN | MGI PHARMA INC | Rodgers Richard J | VP & Controller | Option Exercise | A | 23.56 | 6,500 | 153,140 | 6,500 | |
| Oct 05 2005 | MOGN | MGI PHARMA INC | Rodgers Richard J | VP & Controller | Grant | A | 0.00 | 2,000 | 0 | 3,355 | 1.4 K to 3.4 K (+147.60 %) |
| Oct 03 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 23.24 | 215 | 4,997 | 18,529 | 18.3 K to 18.5 K (+1.17 %) |
| Oct 03 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 23.24 | 215 | 4,997 | 2,759 | 2.5 K to 2.8 K (+8.45 %) |
| Jul 18 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO | Option Exercise | A | 26.91 | 15,000 | 403,650 | 15,000 | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO | Grant | A | 0.00 | 3,000 | 0 | 4,000 | 1,000 to 4 K (+300.00 %) |
| Jul 18 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Grant | A | 0.00 | 5,000 | 0 | 199,000 | 194 K to 199 K (+2.58 %) |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Rodgers Richard J | Option Exercise | A | 26.91 | 8,000 | 215,280 | 8,000 | ||
| Jul 18 2005 | MOGN | MGI PHARMA INC | Rodgers Richard J | Grant | A | 0.00 | 950 | 0 | 1,355 | 405 to 1.4 K (+234.57 %) | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Option Exercise | A | 26.91 | 15,000 | 403,650 | 15,000 | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Grant | A | 0.00 | 3,000 | 0 | 14,676 | 11.7 K to 14.7 K (+25.69 %) |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Option Exercise | A | 26.91 | 17,500 | 470,925 | 17,500 | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Duvall Martin J | Sr VP Commercial Op ... | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Loukas Eric P | VP, General Counsel ... | Option Exercise | A | 26.91 | 17,500 | 470,925 | 17,500 | |
| Jul 18 2005 | MOGN | MGI PHARMA INC | Loukas Eric P | VP, General Counsel ... | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
| Jul 01 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 21.75 | 230 | 5,003 | 18,314 | 18.1 K to 18.3 K (+1.27 %) |
| Jul 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 21.75 | 230 | 5,003 | 2,544 | 2.3 K to 2.5 K (+9.94 %) |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | M | 8.59 | 2,500 | 21,463 | 22,500 | |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | M | 3.55 | 3,750 | 13,313 | 7,500 | |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | M | 5.01 | 3,750 | 18,769 | 3,750 | |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 23.13 | 10,000 | 231,276 | 2,314 | 12.3 K to 2.3 K (-81.21 %) |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | M | 8.59 | 2,500 | 21,463 | 12,314 | 14.8 K to 12.3 K (-16.88 %) |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | M | 3.55 | 3,750 | 13,313 | 9,814 | 13.6 K to 9.8 K (-27.65 %) |
| Jun 06 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Buy | M | 5.01 | 3,750 | 18,769 | 6,064 | 2.3 K to 6.1 K (+162.06 %) |
| May 12 2005 | MOGN | MGI PHARMA INC | MEHRER EDWARD W | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| May 11 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| May 11 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| May 11 2005 | MOGN | MGI PHARMA INC | SHARROCK DAVID B | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| May 11 2005 | MOGN | MGI PHARMA INC | TUTTLE WANETA C | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| May 11 2005 | MOGN | MGI PHARMA INC | WEAVER ARTHUR L | Director | Option Exercise | A | 24.18 | 15,000 | 362,700 | 15,000 | |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Option Exercise | M | 8.59 | 7,500 | 64,388 | 22,500 | |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.10 | 100 | 2,410 | 2,116 | 2.2 K to 2.1 K (-4.51 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.05 | 405 | 9,740 | 2,216 | 2.6 K to 2.2 K (-15.45 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.11 | 1,295 | 31,222 | 2,621 | 3.9 K to 2.6 K (-33.07 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.12 | 800 | 19,296 | 3,916 | 4.7 K to 3.9 K (-16.96 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.07 | 1,000 | 24,070 | 4,716 | 5.7 K to 4.7 K (-17.49 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.08 | 1,900 | 45,752 | 5,716 | 7.6 K to 5.7 K (-24.95 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Sell | S | 24.09 | 2,000 | 48,180 | 7,616 | 9.6 K to 7.6 K (-20.80 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Buy | M | 8.59 | 7,500 | 64,388 | 9,616 | 2.1 K to 9.6 K (+354.44 %) |
| Apr 04 2005 | MOGN | MGI PHARMA INC | FERRARA ANDREW J | Director | Grant | A | 25.27 | 198 | 5,003 | 2,314 | 2.1 K to 2.3 K (+9.36 %) |
| Apr 01 2005 | MOGN | MGI PHARMA INC | MILLER HUGH E | Director | Grant | A | 25.27 | 198 | 5,003 | 18,084 | 17.9 K to 18.1 K (+1.11 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.31 | 213 | 5,391 | 85,100 | 85.3 K to 85.1 K (-0.25 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.26 | 500 | 12,630 | 85,313 | 85.8 K to 85.3 K (-0.58 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.25 | 4,800 | 121,200 | 85,813 | 90.6 K to 85.8 K (-5.30 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.24 | 814 | 20,545 | 90,613 | 91.4 K to 90.6 K (-0.89 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.23 | 173 | 4,365 | 91,427 | 91.6 K to 91.4 K (-0.19 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.17 | 1,219 | 30,682 | 91,600 | 92.8 K to 91.6 K (-1.31 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 25.16 | 3,681 | 92,614 | 92,819 | 96.5 K to 92.8 K (-3.81 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.96 | 5,000 | 124,800 | 96,500 | 101.5 K to 96.5 K (-4.93 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.81 | 100 | 2,481 | 101,500 | 101.6 K to 101.5 K (-0.10 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.80 | 3,400 | 84,320 | 101,600 | 105 K to 101.6 K (-3.24 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.77 | 1,255 | 31,086 | 105,000 | 106.3 K to 105 K (-1.18 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.76 | 1,700 | 42,092 | 106,255 | 108 K to 106.3 K (-1.57 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.75 | 1,045 | 25,864 | 107,955 | 109 K to 108 K (-0.96 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.73 | 1,500 | 37,095 | 109,000 | 110.5 K to 109 K (-1.36 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | SCHROEDER LEE J | Director | Sell | S | 24.70 | 1,000 | 24,700 | 110,500 | 111.5 K to 110.5 K (-0.90 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO Ele ... | Buy | P | 25.20 | 600 | 15,120 | 1,000 | 400 to 1,000 (+150.00 %) |
| Feb 16 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO Ele ... | Buy | P | 25.19 | 400 | 10,076 | 400 | 0 to 400 |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Option Exercise | M | 1.97 | 20,000 | 39,376 | 0 | |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Option Exercise | M | 2.29 | 250 | 572 | 0 | |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Option Exercise | M | 2.29 | 2,250 | 5,150 | 250 | |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Option Exercise | M | 2.41 | 7,750 | 18,649 | 0 | |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Sell | S | 25.03 | 20,250 | 506,868 | 11,676 | 31.9 K to 11.7 K (-63.43 %) |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Buy | M | 1.97 | 20,000 | 39,376 | 31,926 | 11.9 K to 31.9 K (+167.70 %) |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Buy | M | 2.29 | 250 | 572 | 11,926 | 11.7 K to 11.9 K (+2.14 %) |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Sell | S | 25.00 | 10,000 | 250,000 | 11,676 | 21.7 K to 11.7 K (-46.13 %) |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Buy | M | 2.29 | 2,250 | 5,150 | 21,676 | 19.4 K to 21.7 K (+11.58 %) |
| Feb 15 2005 | MOGN | MGI PHARMA INC | MACDONALD JOHN R | Sr. VP, Research & ... | Buy | M | 2.41 | 7,750 | 18,649 | 19,426 | 11.7 K to 19.4 K (+66.38 %) |
| Feb 02 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO Ele ... | Option Exercise | A | 22.69 | 20,000 | 453,800 | 20,000 | |
| Feb 02 2005 | MOGN | MGI PHARMA INC | HAWLEY JAMES C | Senior VP & CFO Ele ... | Option Exercise | A | 22.69 | 30,000 | 680,700 | 30,000 | |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Option Exercise | M | 3.65 | 30,000 | 109,500 | 15,000 | |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Option Exercise | M | 3.55 | 25,000 | 88,750 | 12,500 | |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Option Exercise | M | 5.13 | 15,000 | 76,875 | 37,500 | |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | M | 3.65 | 30,000 | 109,500 | 194,000 | 164 K to 194 K (+18.29 %) |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | M | 3.55 | 25,000 | 88,750 | 164,000 | 139 K to 164 K (+17.99 %) |
| Jan 27 2005 | MOGN | MGI PHARMA INC | MOULDER LEON O JR | President & CEO | Buy | M | 5.13 | 15,000 | 76,875 | 139,000 | 124 K to 139 K (+12.10 %) |
| Jan 25 2005 | MOGN | MGI PHARMA INC | BROWN WILLIAM C | Executive VP & CFO | Option Exercise | M | 3.71 | 30,000 | 111,150 | 0 | |
| Jan 25 2005 | MOGN | MGI PHARMA INC | BROWN WILLIAM C | Executive VP & CFO | Option Exercise | M | 3.65 | 20,000 | 73,000 | 10,000 |